Literature DB >> 21472104

Impaired gluconeogenesis in a porcine model of paracetamol induced acute liver failure.

Konstantinos J Dabos1, Henry R Whalen, Philip N Newsome, John A Parkinson, Neil C Henderson, Ian H Sadler, Peter C Hayes, John N Plevris.   

Abstract

AIM: To investigate glucose homeostasis and in particular gluconeogenesis in a large animal model of acute liver failure (ALF).
METHODS: Six pigs with paracetamol induced ALF under general anaesthesia were studied over 25 h. Plasma samples were withdrawn every five hours from a central vein. Three animals were used as controls and were maintained under anaesthesia only. Using (1)H NMR spectroscopy we identified most gluconeogenic amino acids along with lactate and pyruvate in the animal plasma samples.
RESULTS: No significant changes were observed in the concentrations of the amino acids studied in the animals maintained under anaesthesia only. If we look at the ALF animals, we observed a statistically significant rise of lactate (P < 0.003) and pyruvate (P < 0.018) at the end of the experiments. We also observed statistically significant rises in the concentrations of alanine (P < 0.002), glycine (P < 0.005), threonine (P < 0.048), tyrosine (P < 0.000), phenylalanine (P < 0.000) and isoleucine (P < 0.01). Valine levels decreased significantly (P < 0.05).
CONCLUSION: Our pig model of ALF is characterized by an altered gluconeogenetic capacity, an impaired tricarboxylic acid (TCA) cycle and a glycolytic state.

Entities:  

Keywords:  Aromatic amino acids; Branch chain amino acids; Lactate; Pyruvate

Mesh:

Substances:

Year:  2011        PMID: 21472104      PMCID: PMC3070019          DOI: 10.3748/wjg.v17.i11.1457

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study.

Authors:  William Bernal; Nora Donaldson; Duncan Wyncoll; Julia Wendon
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

2.  Hepatic gluconeogenesis and Krebs cycle fluxes in a CCl4 model of acute liver failure.

Authors:  Rui A Carvalho; John G Jones; Chris McGuirk; A Dean Sherry; Craig R Malloy
Journal:  NMR Biomed       Date:  2002-02       Impact factor: 4.044

3.  Amino acid kinetics during the anhepatic phase of liver transplantation.

Authors:  Alberto Battezzati; Andrea Caumo; Annalisa Fattorini; Lucia Piceni Sereni; Jorgelina Coppa; Raffaele Romito; Mario Ammatuna; Enrico Regalia; Vincenzo Mazzaferro; Livio Luzi
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

4.  Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model.

Authors:  K Arai; K Lee; F Berthiaume; R G Tompkins; M L Yarmush
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

5.  A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha.

Authors:  M Shito; U J Balis; R G Tompkins; M L Yarmush; M Toner
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

6.  Development of an invasively monitored porcine model of acetaminophen-induced acute liver failure.

Authors:  Philip N Newsome; Neil C Henderson; Leonard J Nelson; Costas Dabos; Celine Filippi; Chris Bellamy; Forbes Howie; Richard E Clutton; Tim King; Alistair Lee; Peter C Hayes; John N Plevris
Journal:  BMC Gastroenterol       Date:  2010-03-30       Impact factor: 3.067

7.  Follow-up by one- and two-dimensional NMR of plasma from pigs with ischemia-induced acute liver failure treated with a bioartificial liver.

Authors:  David Tréhout; Mireille Desille; Bich-Thuy Doan; Stephan Mahler; Benjamin Frémond; Yannick Mallédant; Jean-Pierre Campion; Jeanne Desbois; Jean-Claude Beloeil; Jacques de Certaines; Bruno Clément
Journal:  NMR Biomed       Date:  2002-10       Impact factor: 4.044

8.  L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.

Authors:  Nathan A Davies; Gavin Wright; Lars M Ytrebø; Vanessa Stadlbauer; Ole-Martin Fuskevåg; Claudia Zwingmann; D Ceri Davies; Abeba Habtesion; Stephen J Hodges; Rajiv Jalan
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

9.  Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.

Authors:  Subrat Kumar Acharya; Vikram Bhatia; Vishnubhatla Sreenivas; Shankar Khanal; Subrat Kumar Panda
Journal:  Gastroenterology       Date:  2009-06       Impact factor: 22.682

10.  L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.

Authors:  Lars Marius Ytrebø; Rune Gangsøy Kristiansen; Hanne Maehre; Ole Martin Fuskevåg; Trine Kalstad; Arthur Revhaug; María Jover Cobos; Rajiv Jalan; Christopher F Rose
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

View more
  4 in total

Review 1.  Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.

Authors:  Rune Gangsoy Kristiansen
Journal:  Metab Brain Dis       Date:  2016-09-21       Impact factor: 3.584

2.  The cytochrome c oxidase and its mitochondrial function in the whiteleg shrimp Litopenaeus vannamei during hypoxia.

Authors:  L R Jimenez-Gutierrez; S Uribe-Carvajal; A Sanchez-Paz; C Chimeo; A Muhlia-Almazan
Journal:  J Bioenerg Biomembr       Date:  2013-12-17       Impact factor: 2.945

3.  Metabolomics Analysis of Urine Samples from Children after Acetaminophen Overdose.

Authors:  Laura K Schnackenberg; Jinchun Sun; Sudeepa Bhattacharyya; Pritmohinder Gill; Laura P James; Richard D Beger
Journal:  Metabolites       Date:  2017-09-06

4.  Metabolism and Effects on Endogenous Metabolism of Paracetamol (Acetaminophen) in a Porcine Model of Liver Failure.

Authors:  Rebecca Dargue; Rabiya Zia; Chungho Lau; Andrew W Nicholls; Theo O Dare; Karla Lee; Rajiv Jalan; Muireann Coen; Ian D Wilson
Journal:  Toxicol Sci       Date:  2020-05-01       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.